Trisalus Life SciencesTLSI
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 28 institutions reported holding Trisalus Life Sciences Inc. (TLSI) in their 13F filings, down 3 from Q3 2024. 3 opened new positions and 6 sold out. The largest holders were Wealthcare Advisory Partners LLC ($3.2M), Vanguard Group Inc. ($2.4M) and Duquesne Family Office ($2.1M). 3 famous investors held it, including Stanley Druckenmiller (0.1% of Duquesne Family Office's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Trisalus Life Sciences Inc.
- CUSIP
- 89680M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $208K |
| Exits | 6 | $347K |
All 13F filers, Q3 2024 → Q4 2024: 348,666 shares bought and 174,196 shares sold, net +174,470 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Wealthcare Advisory Partners LLC | 0.09% | No change | 643,740 | $3.2M |
| Vanguard Group Inc. | 0.00% | Add +14.5% | 476,292 | $2.4M |
| Duquesne Family Office | 0.06% | No change | 426,921 | $2.1M |
| Geode Capital Management, LLC | 0.00% | Add +1.9% | 204,137 | $1.0M |
| Bank of America Corp. | 0.00% | Add +120471.6% | 178,446 | $894K |
| Millennium Management | 0.00% | Reduce -17.7% | 80,538 | $403K |
| Bridgeway Capital Management, LLC | 0.01% | Add +333.3% | 65,000 | $326K |
| MSD Partners, L.P. | 0.14% | No change | 39,999 | $200K |
| Northern Trust Corp. | 0.00% | Add +22.7% | 32,112 | $161K |
| BlackRock, Inc. | 0.00% | No change | 30,270 | $152K |
| Connective Capital Management, LLC | 0.16% | New | 27,989 | $140K |
| Vestcor Inc | 0.00% | No change | 23,376 | $117K |
| Connecticut Wealth Management, LLC | 0.01% | Reduce -32.2% | 22,303 | $112K |
| State Street Corp. | 0.00% | Add +82.0% | 20,200 | $101K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 15,554 | $78K |
| Gilder Gagnon Howe & Co. LLC | 0.00% | Reduce -0.1% | 14,420 | $72K |
| Lido Advisors, LLC | 0.00% | Reduce -60.0% | 14,024 | $70K |
| Renaissance Technologies | 0.00% | New | 13,400 | $67K |
| Angelo Gordon & Co., L.P. | 0.01% | Reduce -48.0% | 10,854 | $54K |
| Exos Asset Management LLC | 100.00% | Reduce -90.7% | 3,604 | $18K |
| Wolverine Asset Management LLC | 0.00% | Reduce -78.3% | 1,032 | $5K |
| Hoertkorn Richard Charles | 0.00% | No change | 668 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -67.4% | 555 | $3K |
| Signaturefd, LLC | 0.00% | No change | 100 | $501 |
| Osaic Holdings, Inc. | 0.00% | New | 79 | $395 |
| JPMorgan Chase & Co. | 0.00% | Reduce -4.0% | 24 | $120 |
| UBS Group AG | 0.00% | No change | 22 | $110 |
| Wells Fargo & Company | 0.00% | No change | 1 | $5 |
"% of holder's portfolio" is TLSI's weight in each manager's 13F, not the share of Trisalus Life Sciences Inc. the manager owns.